147 related articles for article (PubMed ID: 31309645)
1. Comorbidity in multiple sclerosis: its temporal relationships with disease onset and dose effect on mortality.
Chou IJ; Kuo CF; Tanasescu R; Tench CR; Tiley CG; Constantinescu CS; Whitehouse WP
Eur J Neurol; 2020 Jan; 27(1):105-112. PubMed ID: 31309645
[TBL] [Abstract][Full Text] [Related]
2. Temporal relationships between systemic lupus erythematosus and comorbidities.
Kuo CF; Chou IJ; Rees F; Grainge MJ; Lanyon P; Davenport G; Mallen CD; Chung TT; Chen JS; Zhang W; Doherty M
Rheumatology (Oxford); 2019 May; 58(5):840-848. PubMed ID: 30590795
[TBL] [Abstract][Full Text] [Related]
3. Epilepsy and associated mortality in patients with multiple sclerosis.
Chou IJ; Kuo CF; Tanasescu R; Tench CR; Tiley CG; Constantinescu CS; Whitehouse WP
Eur J Neurol; 2019 Feb; 26(2):342-e23. PubMed ID: 30312502
[TBL] [Abstract][Full Text] [Related]
4. Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.
Thormann A; Magyari M; Koch-Henriksen N; Laursen B; Sørensen PS
J Neurol; 2016 Dec; 263(12):2484-2493. PubMed ID: 27699465
[TBL] [Abstract][Full Text] [Related]
5. Effect of comorbidity on mortality in multiple sclerosis.
Marrie RA; Elliott L; Marriott J; Cossoy M; Blanchard J; Leung S; Yu N
Neurology; 2015 Jul; 85(3):240-7. PubMed ID: 26019190
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of multiple sclerosis: results from a large observational study in the UK.
Jick SS; Li L; Falcone GJ; Vassilev ZP; Wallander MA
J Neurol; 2015 Sep; 262(9):2033-41. PubMed ID: 26067217
[TBL] [Abstract][Full Text] [Related]
7. Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid.
Kibsgaard L; Rasmussen M; Lamberg A; Deleuran M; Olesen AB; Vestergaard C
Br J Dermatol; 2017 Jun; 176(6):1486-1491. PubMed ID: 28235244
[TBL] [Abstract][Full Text] [Related]
8. Common comorbidities and survival in MS: Risk for stroke, type 1 diabetes and infections.
Murtonen A; Kurki S; Hänninen K; Soilu-Hänninen M; Sumelahti ML
Mult Scler Relat Disord; 2018 Jan; 19():109-114. PubMed ID: 29190573
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities in patients with gout prior to and following diagnosis: case-control study.
Kuo CF; Grainge MJ; Mallen C; Zhang W; Doherty M
Ann Rheum Dis; 2016 Jan; 75(1):210-7. PubMed ID: 25398375
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Survival in Multiple Sclerosis: A Matched Cohort Study.
Marrie RA; Maxwell C; Mahar A; Ekuma O; McClintock C; Seitz D; Groome P
Neurology; 2021 Jul; 97(1):e13-e22. PubMed ID: 34011575
[TBL] [Abstract][Full Text] [Related]
11. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.
Marrie RA; Rudick R; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
Neurology; 2010 Mar; 74(13):1041-7. PubMed ID: 20350978
[TBL] [Abstract][Full Text] [Related]
12. Mortality of patients with multiple sclerosis: a cohort study in UK primary care.
Jick SS; Li L; Falcone GJ; Vassilev ZP; Wallander MA
J Neurol; 2014 Aug; 261(8):1508-17. PubMed ID: 24838537
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England.
Palladino R; Marrie RA; Majeed A; Chataway J
JAMA Neurol; 2020 Jul; 77(7):820-828. PubMed ID: 32364569
[TBL] [Abstract][Full Text] [Related]
14. Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database.
Capkun G; Dahlke F; Lahoz R; Nordstrom B; Tilson HH; Cutter G; Bischof D; Moore A; Simeone J; Fraeman K; Bancken F; Geissbühler Y; Wagner M; Cohan S
Mult Scler Relat Disord; 2015 Nov; 4(6):546-54. PubMed ID: 26590661
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis mortality and patterns of comorbidity in the United States from 1990 to 2001.
Redelings MD; McCoy L; Sorvillo F
Neuroepidemiology; 2006; 26(2):102-7. PubMed ID: 16374035
[TBL] [Abstract][Full Text] [Related]
16. Temporal relationship between osteoarthritis and comorbidities: a combined case control and cohort study in the UK primary care setting.
Swain S; Coupland C; Mallen C; Kuo CF; Sarmanova A; Bierma-Zeinstra SMA; Englund M; Prieto-Alhambra D; Doherty M; Zhang W
Rheumatology (Oxford); 2021 Sep; 60(9):4327-4339. PubMed ID: 33506862
[TBL] [Abstract][Full Text] [Related]
17. Causes of death among persons with multiple sclerosis.
Cutter GR; Zimmerman J; Salter AR; Knappertz V; Suarez G; Waterbor J; Howard VJ; Marrie RA
Mult Scler Relat Disord; 2015 Sep; 4(5):484-490. PubMed ID: 26346799
[TBL] [Abstract][Full Text] [Related]
18. Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis.
Simpson RJ; McLean G; Guthrie B; Mair F; Mercer SW
BMC Neurol; 2014 Jun; 14():128. PubMed ID: 24925477
[TBL] [Abstract][Full Text] [Related]
19. QT prolongation predicts short-term mortality independent of comorbidity.
Gibbs C; Thalamus J; Kristoffersen DT; Svendsen MV; Holla ØL; Heldal K; Haugaa KH; Hysing J
Europace; 2019 Aug; 21(8):1254-1260. PubMed ID: 31220237
[TBL] [Abstract][Full Text] [Related]
20. Association between comorbidity and clinical characteristics of MS.
Marrie RA; Horwitz RI; Cutter G; Tyry T; Vollmer T
Acta Neurol Scand; 2011 Aug; 124(2):135-41. PubMed ID: 20880264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
